COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 202: Articles 2011-2020  | Next

Design of Antigen-Specific Antibody CDRH3 Sequences Using AI and Germline-Based Templates
Marinov, T. M., Abu-Shmais, A., Janke, A. K., Georgiev, I.
10.1101/2024.03.22.586241 — Posted: 2024-03-22
Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants
Fryer, H. A., Geers, D., Gommers, L., Zaeck, L. M., Tan, N. H., Jones-Freeman, B., Goorhuis, A., Postma, D. F., Visser, L. G., Hogarth, P. M., Koopmans, M. P. G., GeurtsvanKessel, C. H., O'Hehir, R. E., van der Kuy, P. H. M., de Vries, R. D., van Zelm, M. C.
10.1101/2024.03.20.585861 — Posted: 2024-03-22
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2
Wang, J., Beyer, D., Vaccarin, C., He, Y., Tanriver, M., Benoit, R. M., Deupi, X., Mu, L., Bode, J. W., Schibli, r., Mueller, C.
10.1101/2024.03.20.585792 — Posted: 2024-03-21
SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids
Chau, C. W., To, A., Au-Yeung, R. K. H., Tang, K., Xiang, Y., Ruan, D., Zhang, L., Wong, H., Zhang, S., Au, M. T., Chung, S., Song, E., Choi, D.-H., Liu, P., Yuan, S., Wen, C., Sugimura, R.
10.1101/2024.03.20.585837 — Posted: 2024-03-21
Deep learning of antibody epitopes using molecular permutation vectors
Vardaxis, I., Simovski, B., Anzar, I., Stratford, R., Clancy, T.
10.1101/2024.03.20.585661 — Posted: 2024-03-21
Impact of COVID-19 Pandemic on Colonoscopy Wait Times by Procedure Indication
Thibault, M., Barkun, A., Martel, M., Russell, A. W.
10.1101/2024.03.20.24304332 — Posted: 2024-03-21
Exploring the Psychological, Social, and Human Rights Dynamics and Consequences of COVID-19 Control Measures: A Systematic Review
Spasojevic, D.
10.1101/2024.03.18.24304509 — Posted: 2024-03-21
Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled Trial
Kwan, A. T. H., Lakhani, M., Le, G. H., Singh, G., Teopiz, K. M., Ceban, F., Nijjar, C. S., Meshkat, S., Badulescu, S., Ho, R., Rhee, T. G., Vincenzo, J. D., Gill, H., McIntyre, R. S.
10.1101/2024.03.20.24304410 — Posted: 2024-03-21
Validation of RT-qPCR primers and probes for new and old variants of SARS-CoV-2 in a world scale
Almeida, A. F. R., Almeida, W. A., Pereira, W. M., Silva, R. d. S., Venancio, L. P. R., Fabres-Klein, M. H., Lima, J. B., Klein, R. C., Araujo-Santos, T.
10.1101/2024.03.19.585194 — Posted: 2024-03-20
Quantitating SARS-CoV-2 Neutralizing Antibodies from Human Dried Blood Spots
Berman, K., Van Slyke, G., Novak, H., Rock, J., Bievenue, R., Damjanovic, A., DeRosa, K., Mirabile, G., Giradin, R., Dupuis, A., McDonough, K., Parker, M. M., Styer, L., MANTIS, N. J.
10.1101/2024.03.18.585599 — Posted: 2024-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).